We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+12.41%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$27.2B
AUM Growth
+$1.69B
(+6.6%)
Cap. Flow
-$837M
Cap. Flow
% of AUM
-3.08%
Top 10 Holdings %
Top 10 Hldgs %
35.28%
Holding
550
New
72
Increased
170
Reduced
177
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$151M |
| 2 |
JPMorgan Chase
JPM
|
+$120M |
| 3 |
Qualcomm
QCOM
|
+$115M |
| 4 |
VeriSign
VRSN
|
+$107M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$376M |
| 2 |
Microsoft
MSFT
|
+$285M |
| 3 |
Home Depot
HD
|
+$167M |
| 4 |
Abbott
ABT
|
+$157M |
| 5 |
Sherwin-Williams
SHW
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.58% |
| 2 | Healthcare | 21.35% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Financials | 10.29% |
| 5 | Communication Services | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Rocket Pharmaceuticals
RCKT
$344M
| $592K | ﹤0.01% |
+26,000
| New | +$434K |
|
|
FTSV
377
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $591K | ﹤0.01% |
+15,000
| New | +$241K |
|
|
AMED
378
DELISTED
Amedisys
AMED
| $584K | ﹤0.01% |
+3,500
| New | +$521K |
|
379
Qiagen
QGEN
$8.74B
| $573K | ﹤0.01% |
+16,000
| New | +$595K |
|
|
SWAV
380
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $571K | ﹤0.01% |
13,000
+3,000
| +30% | +$111K |
|
381
American Express
AXP
$226B
| $548K | ﹤0.01% |
4,400
| – | – |
|
382
DuPont de Nemours
DD
$19.2B
| $539K | ﹤0.01% |
6,694
| – | – |
|
383
Idexx Laboratories
IDXX
$45.5B
| $524K | ﹤0.01% |
2,006
-25,509
| -93% | -$6.72M |
|
384
Endava
DAVA
$154M
| $522K | ﹤0.01% |
11,209
-9,045
| -45% | -$390K |
|
385
uniQure
QURE
$2.47B
| $502K | ﹤0.01% |
+7,000
| New | +$384K |
|
386
Protolabs
PRLB
$1.82B
| $498K | ﹤0.01% |
4,907
-2,402
| -33% | -$238K |
|
387
Xylem
XYL
$29.8B
| $483K | ﹤0.01% |
6,134
-3,671
| -37% | -$286K |
|
388
Tetra Tech
TTEK
$8.5B
| $482K | ﹤0.01% |
27,955
-12,220
| -30% | -$212K |
|
389
Woodward
WWD
$24.5B
| $478K | ﹤0.01% |
4,037
-775
| -16% | -$87.5K |
|
|
ALLK
390
DELISTED
Allakos
ALLK
| $477K | ﹤0.01% |
+5,000
| New | +$440K |
|
391
Gossamer Bio
GOSS
$107M
| $469K | ﹤0.01% |
30,000
| – | – |
|
392
Dow Inc
DOW
$21.2B
| $460K | ﹤0.01% |
8,403
| – | – |
|
|
APLS
393
DELISTED
Apellis Pharmaceuticals
APLS
| $459K | ﹤0.01% |
15,000
-16,000
| -52% | -$443K |
|
394
NMI Holdings
NMIH
$3.33B
| $455K | ﹤0.01% |
13,700
-1,600
| -10% | -$50K |
|
395
Mesa Laboratories
MLAB
$559M
| $415K | ﹤0.01% |
1,665
+272
| +20% | +$63.7K |
|
396
Personalis
PSNL
$1.26B
| $400K | ﹤0.01% |
36,732
-79,225
| -68% | -$825K |
|
397
Agilent Technologies
A
$40.2B
| $394K | ﹤0.01% |
4,621
| – | – |
|
|
SILK
398
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $373K | ﹤0.01% |
9,233
+1,233
| +15% | +$43.2K |
|
|
STML
399
DELISTED
Stemline Therapeutics, Inc.
STML
| $372K | ﹤0.01% |
35,000
| – | – |
|
400
Electronic Arts
EA
$52.5B
| $360K | ﹤0.01% |
3,344
| – | – |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q4 2019 Portfolio in Review
As of Q4 2019, Fred Alger Management held 550 positions worth $27.2B, up 6.6% from $25.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Fred Alger Management withdrew a net $837M in Q4 2019, closing 71 positions and reducing 177 holdings. Its most notable exit was iRhythm Holdings, an estimated $39.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in CrowdStrike worth $41.4M.
- Fred Alger Management's largest Q4 2019 buy was CrowdStrike: 3,323,112 shares worth $41.4M.
- Fred Alger Management added most to UnitedHealth in Q4 2019, an estimated $151M increase.
- Fred Alger Management's biggest Q4 2019 reduction was Amazon, cutting an estimated $376M.
- Fred Alger Management fully exited iRhythm Holdings in Q4 2019, selling an estimated $39.8M.
- Fred Alger Management's ten largest holdings make up 35% of its $27.2B portfolio in Q4 2019.
- Fred Alger Management opened 72 new positions and closed 71 in Q4 2019.
- Fred Alger Management's portfolio value rose 6.6% quarter-over-quarter to $27.2B.
Based on Fred Alger Management's 13F filing for Q4 2019, filed 14 Feb 2020.